Skip to main content

COVID-19 vaccine: Serum Institute gets DCGI’s nod to manufacture Sputnik V vaccine in India

Serum Institute of India has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Russia for developing the Sputnik V vaccine at its licensed Hadapsar facility.


Popular posts from this blog

Parliamentary panel on Information Technology summons Facebook, Google on June 29

India’s Permanent Mission at the United Nations, on June 20, 2021, had clarified that the new Information Technology rules introduced by India have been ‘designed to empower the ordinary users of social media'. source